• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

It's moving day: factors affecting peripheral blood stem cell mobilization and strategies for improvement [corrected].

作者信息

Fruehauf Stefan, Seggewiss Ruth

机构信息

Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.

出版信息

Br J Haematol. 2003 Aug;122(3):360-75. doi: 10.1046/j.1365-2141.2003.04483.x.

DOI:10.1046/j.1365-2141.2003.04483.x
PMID:12877663
Abstract
摘要

相似文献

1
It's moving day: factors affecting peripheral blood stem cell mobilization and strategies for improvement [corrected].移植日：影响外周血干细胞动员的因素及改进策略[已校正]
Br J Haematol. 2003 Aug;122(3):360-75. doi: 10.1046/j.1365-2141.2003.04483.x.
2
Plerixafor (Mozobil).普乐沙福（莫泽比利）。
Med Lett Drugs Ther. 2010 Apr 5;52(1335):27-8.
3
Advances in stem cell mobilization.干细胞动员的研究进展。
Blood Rev. 2012 Nov;26(6):267-78. doi: 10.1016/j.blre.2012.09.003. Epub 2012 Oct 12.
4
The use of growth factors in hematopoietic stem cell transplantation.生长因子在造血干细胞移植中的应用。
Curr Pharm Des. 2008;14(20):1950-61. doi: 10.2174/138161208785061427.
5
Mobilization of PBSCs in poor mobilizers with POEMS syndrome using G-CSF with plerixafor.使用粒细胞集落刺激因子（G-CSF）联合普乐沙福动员POEMS综合征中动员效果不佳者的外周血造血干细胞
Bone Marrow Transplant. 2012 Dec;47(12):1587-8. doi: 10.1038/bmt.2012.80. Epub 2012 May 21.
6
Plerixafor, cyclophosphamide and G-CSF and Blood cell mobilization in a patient with acute promyelocytic leukemia.
J Clin Apher. 2017 Dec;32(6):592-593. doi: 10.1002/jca.21516. Epub 2016 Oct 27.
7
Peripheral blood CD34+ cell monitoring after cyclophosphamide and granulocyte-colony-stimulating factor: an algorithm for the pre-emptive use of plerixafor.环磷酰胺和粒细胞集落刺激因子治疗后的外周血CD34+细胞监测：普乐沙福预先使用的算法
Leuk Lymphoma. 2014 Feb;55(2):331-6. doi: 10.3109/10428194.2013.802783. Epub 2013 Jun 14.
8
Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.粒细胞集落刺激因子与粒细胞巨噬细胞集落刺激因子联合强化化疗用于多发性骨髓瘤外周血干细胞动员和自体移植的随机对照研究
Biol Blood Marrow Transplant. 2004 Jun;10(6):395-404. doi: 10.1016/j.bbmt.2004.02.001.
9
Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.对225例接受自体移植的患者采用中剂量环磷酰胺、序贯应用粒细胞巨噬细胞集落刺激因子和粒细胞集落刺激因子进行外周血祖细胞动员，并安排开始白细胞分离术。
Transfusion. 2007 Nov;47(11):2153-60. doi: 10.1111/j.1537-2995.2007.01440.x.
10
Impact of Single-Dose Plerixafor as an Adjunct to Granulocyte Colony-Stimulating Factor-Based Peripheral Blood Stem Cell Mobilization on the Graft Composition and Outcome for T Cell-Replete Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Comparative Study.单次注射培洛昔芳联合粒细胞集落刺激因子对 T 细胞去除的单倍体外周血造血干细胞移植后环磷酰胺移植后移植物组成和结果的影响：一项比较研究。
Biol Blood Marrow Transplant. 2018 Mar;24(3):542-548. doi: 10.1016/j.bbmt.2017.11.014. Epub 2017 Dec 5.

引用本文的文献

1
Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma.预测霍奇金和非霍奇金淋巴瘤患者的干细胞动员失败。
Turk J Haematol. 2021 Aug 25;38(3):204-210. doi: 10.4274/tjh.galenos.2020.2020.0409. Epub 2020 Nov 9.
2
Expression of adhesion molecules on CD34+ cells from steady-state bone marrow before and after mobilization and their association with the yield of CD34+ cells.动员前后稳态骨髓中CD34+细胞黏附分子的表达及其与CD34+细胞产量的关系。
Blood Res. 2018 Mar;53(1):61-70. doi: 10.5045/br.2018.53.1.61. Epub 2018 Mar 27.
3
Current clinical indications for plerixafor.
普乐沙福目前的临床适应症。
Transfus Med Hemother. 2013 Aug;40(4):246-50. doi: 10.1159/000354229. Epub 2013 Jul 19.
4
Physiology and pharmacology of plerixafor.普乐沙福的生理学与药理学
Transfus Med Hemother. 2013 Aug;40(4):237-45. doi: 10.1159/000354132. Epub 2013 Jul 19.
5
Hematopoietic stem cell mobilization: updated conceptual renditions.造血干细胞动员：更新的概念表述。
Leukemia. 2013 Jan;27(1):24-31. doi: 10.1038/leu.2012.254. Epub 2012 Sep 6.
6
Many mechanisms mediating mobilization: an alliterative review.多种机制介导动员：一种头韵的综述。
Curr Opin Hematol. 2011 Jul;18(4):231-8. doi: 10.1097/MOH.0b013e3283477962.
7
Mobilization of hematopoietic stem cells from the bone marrow niche to the blood compartment.造血干细胞从骨髓龛向血液腔的动员。
Stem Cell Res Ther. 2011 Mar 14;2(2):13. doi: 10.1186/scrt54.
8
Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand.外周血干细胞动员：新方案、新细胞，我们目前的状况
Curr Opin Hematol. 2008 Jul;15(4):285-92. doi: 10.1097/MOH.0b013e328302f43a.
9
Chemokine-mobilized adult stem cells; defining a better hematopoietic graft.趋化因子动员的成体干细胞；定义更好的造血移植物。
Leukemia. 2008 Mar;22(3):466-73. doi: 10.1038/sj.leu.2405021. Epub 2007 Nov 1.
10
Pilot study of ifosfamide/carboplatin/etoposide (ICE) for peripheral blood stem cell mobilization in patients with high-risk or relapsed medulloblastoma.异环磷酰胺/卡铂/依托泊苷（ICE）用于高危或复发型髓母细胞瘤患者外周血干细胞动员的初步研究。
Childs Nerv Syst. 2007 Apr;23(4):407-13. doi: 10.1007/s00381-006-0282-5. Epub 2007 Jan 17.